KAM
Krensavage Asset Management Portfolio holdings
AUM
$189M
This Quarter Return
+13.7%
1 Year Return
+19.71%
3 Year Return
+56.44%
5 Year Return
+120.01%
10 Year Return
+215.64%
AUM
$220M
AUM Growth
+$220M
(+22%)
Cap. Flow
+$12.9M
Cap. Flow
% of AUM
5.86%
Top 10 Holdings %
Top 10 Hldgs %
70.24%
Holding
28
New
2
Increased
7
Reduced
10
Closed
5
Top Buys
| 1 |
Enanta Pharmaceuticals
ENTA
|
$13M |
| 2 |
Amgen
AMGN
|
$4.48M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$1.81M |
| 4 |
Avanos Medical
AVNS
|
$1.81M |
| 5 |
United Therapeutics
UTHR
|
$1.03M |
Top Sells
| 1 |
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
|
$4.99M |
| 2 |
MDCO
Medicines Co
MDCO
|
$3.56M |
| 3 |
Assertio
ASRT
|
$874K |
| 4 |
IPXL
Impax Laboratories, Inc.
IPXL
|
$573K |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$435K |
Sector Composition
| 1 | Healthcare | 67.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
United Therapeutics
UTHR
$13.8B
| $22.6M | 10.27% | 130,801 +6,000 | +5% | +$1.03M |
|
|
IPXL
2
DELISTED
Impax Laboratories, Inc.
IPXL
| $19.3M | 8.77% | 410,944 -12,217 | -3% | -$573K |
|
|
AMAG
3
DELISTED
AMAG Pharmaceuticals, Inc.
AMAG
| $18.6M | 8.49% | 341,091 -7,951 | -2% | -$435K |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $15.5M | 7.04% | 248,200 +29,000 | +13% | +$1.81M |
|
|
5
Avanos Medical
AVNS
$554M
| $15M | 6.82% | 304,150 +36,700 | +14% | +$1.81M |
|
|
SCMP
6
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $14.5M | 6.62% | 933,866 -24,182 | -3% | -$376K |
|
|
7
Enanta Pharmaceuticals
ENTA
$180M
| $13M | 5.91% | +424,016 | New | +$13M |
|
8
CONMED
CNMD
$1.68B
| $12.7M | 5.78% | 251,274 -6,843 | -3% | -$346K |
|
9
Merck
MRK
$210B
| $12M | 5.48% | 209,304 +5,204 | +3% | +$299K |
|
10
Orthofix Medical
OFIX
$592M
| $11.1M | 5.06% | 309,698 -2,772 | -0.9% | -$99.5K |
|
|
HRC
11
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $9.23M | 4.2% | 188,327 -7,773 | -4% | -$381K |
|
|
12
Amgen
AMGN
$155B
| $9.11M | 4.15% | 57,000 +28,000 | +97% | +$4.48M |
|
|
SRGA
13
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $8.41M | 3.83% | 1,701,458 +50,000 | +3% | +$247K |
|
|
14
Assertio
ASRT
$80.4M
| $7.7M | 3.51% | 343,546 -38,996 | -10% | -$874K |
|
|
AGN
15
DELISTED
Allergan plc
AGN
| $6.53M | 2.98% | 21,954 -1,062 | -5% | -$316K |
|
|
IVC
16
DELISTED
Invacare Corporation
IVC
| $6.5M | 2.96% | 334,762 | – | – |
|
17
AbbVie
ABBV
$372B
| $4.1M | 1.87% | 70,000 -5,500 | -7% | -$322K |
|
|
VXRT
18
DELISTED
Vaxart
VXRT
| $3.12M | 1.42% | 1,356,652 +209,522 | +18% | +$482K |
|
19
Innoviva
INVA
$1.29B
| $2.53M | 1.15% | 161,188 -10,671 | -6% | -$168K |
|
|
JNP
20
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
| $1.96M | 0.89% | 316,149 | – | – |
|
|
STRR
21
DELISTED
Star Equity Holdings
STRR
| $1.91M | 0.87% | 419,604 | – | – |
|
|
FURX
22
DELISTED
FURIEX PHARMACEUTICALS INC COM STK (DE)
FURX
| $1.42M | 0.65% | 145,544 | – | – |
|
23
Eli Lilly
LLY
$657B
| – | – | -2,143 | Closed | -$148K |
|
24
Pfizer
PFE
$141B
| – | – | -13,447 | Closed | -$419K |
|
|
MNK
25
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| – | – | -50,395 | Closed | -$4.99M |
|